China Cord Blood Corporation is a provider of cord blood banking services in China. The Company and its subsidiaries are principally engaged in the provision of umbilical cord blood storage and ancillary services in the People's Republic of China. It provides cord blood testing, processing and storage services under the direction of subscribers for a cord blood processing fee and a storage fee. It also tests, processes and stores donated cord blood, and provides matching services to the public for a fee. The Company provides cord blood processing and storage services for expectant parents interested in capturing the opportunities made available by evolving medical treatments and technologies, such as cord blood transplants. It also preserves cord blood units donated by the public; provides matching services on such donated units, and delivers matching units to patients in need of transplants. As of March 31, 2016, the Company had three operating cord blood banks.
Industry, Sector and Symbol:
- Sector: Medical
- Industry: Medical Laboratories & Research
- Sub-Industry: N/A
- Symbol: NYSE:CO
- CUSIP: N/A
- Web: www.chinacordbloodcorp.com
- Market Cap: $663.6 million
- Outstanding Shares: 73,003,000
- 50 Day Moving Avg: $7.47
- 200 Day Moving Avg: $6.08
- 52 Week Range: $4.27 - $9.15
Sales & Book Value:
- Trailing P/E Ratio: 47.59
- Foreward P/E Ratio: 53.47
- P/E Growth: 0.00
- Annual Revenue: $103.7 million
- Price / Sales: 6.40
- Book Value: $3.51 per share
- Price / Book: 2.59
- EBIDTA: $43.24 million
- Net Margins: 13.38%
- Return on Equity: 5.30%
- Return on Assets: 1.93%
- Debt-to-Equity Ratio: 0.24%
- Current Ratio: 3.49%
- Quick Ratio: 3.46%
- Average Volume: 217,102 shs.
- Beta: 0.95
- Short Ratio: 2.25
Frequently Asked Questions for China Cord Blood Corp (NYSE:CO)
What is China Cord Blood Corp's stock symbol?
China Cord Blood Corp trades on the New York Stock Exchange (NYSE) under the ticker symbol "CO."
How were China Cord Blood Corp's earnings last quarter?
China Cord Blood Corp (NYSE:CO) released its quarterly earnings data on Monday, August, 22nd. The company reported $0.03 EPS for the quarter, meeting the consensus estimate of $0.03. The business earned $26 million during the quarter, compared to the consensus estimate of $26.23 million. China Cord Blood Corp had a net margin of 13.38% and a return on equity of 5.30%. View China Cord Blood Corp's Earnings History.
When will China Cord Blood Corp make its next earnings announcement?
Who are some of China Cord Blood Corp's key competitors?
Some companies that are related to China Cord Blood Corp include Abaxis (ABAX), Genomic Health (GHDX), Analogic (ALOG), BioTelemetry (BEAT), Heska Corp (HSKA), NeoGenomics (NEO), Natera (NTRA), Novadaq Technologies (NVDQ), Enzo Biochem (ENZ), InVitae Corp (NVTA), RadNet (RDNT), Alliance HealthCare Services (AIQ), Fluidigm (FLDM), Cytosorbents Corp (CTSO), Miragen Therapeutics (MGEN), VolitionRX Ltd (VNRX), Cancer Genetics (CGIX) and Biocept (BIOC).
Who owns China Cord Blood Corp stock?
China Cord Blood Corp's stock is owned by a number of of retail and institutional investors. Top institutional investors include
GOLDEN MEDITECH HOLDINGS LTD
GOLDEN MEDITECH HOLDINGS LTD
(65.40%), Credit Suisse AG (1.56%), Renaissance Technologies LLC (1.18%), Acadian Asset Management LLC (0.81%) and PEAK6 Investments L.P. (0.30%). View Institutional Ownership Trends for China Cord Blood Corp.
Who sold China Cord Blood Corp stock? Who is selling China Cord Blood Corp stock?
China Cord Blood Corp's stock was sold by a variety of institutional investors in the last quarter, including Credit Suisse AG, Bank of America Corp DE, PEAK6 Investments L.P., California Public Employees Retirement System and Parametric Portfolio Associates LLC. View Insider Buying and Selling for China Cord Blood Corp.
Who bought China Cord Blood Corp stock? Who is buying China Cord Blood Corp stock?
China Cord Blood Corp's stock was acquired by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC, Brandes Investment Partners LP, Spark Investment Management LLC, Acadian Asset Management LLC, Financial Counselors Inc. and Commonwealth of Pennsylvania Public School Empls Retrmt SYS. View Insider Buying and Selling for China Cord Blood Corp.
How do I buy China Cord Blood Corp stock?
Shares of China Cord Blood Corp can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
How much does a share of China Cord Blood Corp stock cost?
One share of China Cord Blood Corp stock can currently be purchased for approximately $9.09.
Earnings History for China Cord Blood Corp (NYSE:CO)Earnings History by Quarter for China Cord Blood Corp (NYSE:CO)
(Data available from 1/1/2011 forward)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|6/12/2017|| || || || || || || || |
|11/17/2016||Q217||$0.04||$0.03||$27.37 million||$27.61 million||View||Listen|
|8/22/2016||Q117||$0.03||$0.03||$26.23 million||$26.00 million||View||N/A|
|6/14/2016||Q416||$0.03||$0.03||$25.87 million||$24.31 million||View||Listen|
|11/23/2015||Q216||$0.04||$0.05||$26.42 million||$27.00 million||View||Listen|
|8/19/2015||Q116||$0.04||$0.03||$25.81 million||$26.70 million||View||Listen|
|6/18/2015||Q415||$0.05||$0.04||$25.88 million||$26.30 million||View||Listen|
|2/25/2015||Q315||$0.06||$0.07||$26.35 million||$26.90 million||View||Listen|
|11/25/2014||Q2||$0.06||$0.06||$25.30 million||$24.78 million||View||Listen|
|8/28/2014||Q1||$0.06||$0.06||$24.78 million||$24.72 million||View||Listen|
|6/18/2014||Q414||$0.07||$0.07||$24.41 million||$24.44 million||View||N/A|
|2/24/2014||Q3||$0.06||$0.07||$24.22 million||$24.90 million||View||Listen|
|11/15/2013||Q2||$0.06||$0.06||$22.32 million||$23.10 million||View||Listen|
|8/26/2013||Q1 2014||$0.04||$0.07||$21.62 million||$21.00 million||View||Listen|
|6/18/2013||Q4 2013||$0.02||$0.05||$16.59 million||$21.40 million||View||Listen|
|11/19/2012||Q312||$0.05||$18.53 million||$20.40 million||View||N/A|
Earnings Estimates for China Cord Blood Corp (NYSE:CO)
2017 EPS Consensus Estimate: $0.16
(Data provided by Zacks Investment Research)
|Quarter||Number of Estimates||Low Estimate||High Estimate||Average Estimate|
Dividend History for China Cord Blood Corp (NYSE:CO)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading and Institutional Ownership History for China Cord Blood Corp (NYSE:CO)
Institutional Ownership Percentage: 7.93%Insider Trades by Quarter for China Cord Blood Corp (NYSE:CO)
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Details|
|1/21/2015||Kent C Mccarthy||Insider||Buy||20,000||$4.60||$92,000.00|| |
|1/16/2015||Kent C Mccarthy||Insider||Buy||50,000||$4.30||$215,000.00|| |
|1/14/2015||Private Equity Fund Jayhawk II||Insider||Buy||10,000||$4.52||$45,200.00|| |
|1/12/2015||Private Equity Fund Jayhawk II||Insider||Buy||50,000||$4.69||$234,500.00|| |
|11/28/2014||Robert Douglas Cudney||Insider||Buy||200,000||$0.01||$1,000.00|
|11/17/2014||Kent C Mccarthy||Insider||Buy||26,754||$4.70||$125,743.80|| |
|11/6/2014||Kent C Mccarthy||Insider||Buy||150,000||$5.16||$774,000.00|| |
|9/29/2014||Kent C Mccarthy||Insider||Buy||10,000||$5.00||$50,000.00|| |
|9/10/2014||Kent C Mccarthy||Insider||Buy||9,900||$4.98||$49,302.00|| |
Headline Trends for China Cord Blood Corp (NYSE:CO)
Latest Headlines for China Cord Blood Corp (NYSE:CO)
China Cord Blood Corp (CO) Chart for Friday, May, 26, 2017